drugset

drugset / Trial / NCT03590821

Timed Aspirin Chronobiome Study

NCT03590821 ↗

Phase 0 Not yet recruiting 60 enrolled University of Pennsylvania

RandomizedCrossoverTriple-blindPrevention

Summary

To determine whether timed administration of aspirin ameliorates the effects of celecoxib on blood pressure.

Timeline

Start: 2027-12
Primary completion: 2028-01
Completion: 2028-11

Publications

Background Skarke C, Lahens NF, Rhoades SD, Campbell A, Bittinger K, Bailey A, Hoffmann C, Olson RS, Chen L, Yang G, Price TS, Moore JH, Bushman FD, Greene CS, Grant GR, Weljie AM, FitzGerald GA. A Pilot Characterization of the Human Chronobiome. Sci Rep. 2017 Dec 7;7(1):17141. doi: 10.1038/s41598-017-17362-6.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Aspirin	Small molecule	81 mg	—
Background	Celecoxib	Other / unclassified	200 mg	—

Indications

No indication recorded.